CCL2 and chronic kidney disease: As outlined in the Results section, we have selected MCP1:creatinine and ICAM-1:creatinine as the most promising candidate markers to take forward, because they show the most significant difference across all groups, the highest discrimination from healthy controls and the most potential to differentiate SSc–CKD from other causes of CKD.